Screening and optimization of shark nanobodies against SARS-CoV-2 spike RBD
Xiaochun Liu(AstraZeneca (United States)), Yuchao Gu(Qingdao National Laboratory for Marine Science and Technology), Guokai Xiao(Ocean University of China), Yanqing Wang(Ocean University of China), Ximing Xu(Shanghai Changzheng Hospital), Ning Hou(Peking University), Wei Wang(Sichuan University), Li-shan Sun(Ocean University of China), Jin Chen(Qingdao University of Science and Technology)
Cited by 17
Related Papers
The JAK/STAT signaling pathway: from bench to clinic
|Signal Transduction and Targeted Therapy|2021|2.4k
A new class of membrane-bound chemokine with a CX3C motif
|Nature|1997|2k
Hepatogastroenterology
|Hepatogastroenterology|2012|1.8k
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849
Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
|Scientific Reports|2019|426